tradingkey.logo
tradingkey.logo
Search

Ideaya Biosciences Inc - Servier And Ideaya Enter Exclusive License For Darovasertib Outside Us

ReutersSep 2, 2025 12:23 PM
facebooktwitterlinkedin

IDEAYA Biosciences Inc IDYA.O:

  • IDEAYA BIOSCIENCES INC - SERVIER AND IDEAYA ENTER EXCLUSIVE LICENSE FOR DAROVASERTIB OUTSIDE US

  • IDEAYA BIOSCIENCES INC - TO RECEIVE $210 MILLION UPFRONT, UP TO $320 MILLION IN MILESTONES

  • IDEAYA BIOSCIENCES INC - CO AND SERVIER TO LAUNCH GLOBAL PHASE 3 TRIAL FOR DAROVASERTIB IN 2026

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Recommended Articles

Tradingkey
KeyAI